Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

1. Executive Summary

2. Global Total Market Value of the Top 20 Vaccine Companies (2015 – 2019)

3. Market Share Analysis of the Top 20 Vaccine Companies (%)

4. Key Market Drivers and Inhibitors in the Vaccine Market

• 4.1 Key Market Drivers
• 4.2 Key Market Inhibitors

5. Major Deals and Agreement Happenings in the Vaccine Market

• 5.1 Merger & Acquisitions
• 5.2 Collaboration Deals
• 5.3 Licensing Agreement
• 5.4 Exclusive Agreement
• 5.5 Distribution Agreement
• 5.6 Partnership Deals

6. Top 20 Vaccine Companies in the Vaccine Market

• 6.1 Sanofi Pasteur
  • 6.1.1 Business Overview
  • 6.1.2 Vaccines Portfolio
  • 6.1.3 Vaccines Market Value Analysis
  • 6.1.4 Promising Vaccines in the Clinical Development
  • 6.1.5 Recent Development
• 6.2 GlaxoSmithKline (GSK)
  • 6.2.1 Business Overview
  • 6.2.2 Vaccines Portfolio
  • 6.2.3 Vaccines Market Value Analysis
  • 6.2.4 Promising Vaccines in the Clinical Development
  • 6.2.5 Recent Development
• 6.3 Merck & Co., Inc.
  • 6.3.1 Business Overview
  • 6.3.2 Vaccines Portfolio
  • 6.3.3 Vaccines Market Value Analysis
  • 6.3.4 Promising Vaccines in the Clinical Development
  • 6.3.5 Recent Development
• 6.4 Pfizer
  • 6.4.1 Business Overview
  • 6.4.2 Vaccines Portfolio
  • 6.4.3 Vaccines Market Value Analysis
  • 6.4.4 Promising Vaccines in the Clinical Development
  • 6.4.5 Recent Development
• 6.5 AstraZeneca
  • 6.5.1 Business Overview
  • 6.5.2 Vaccines Portfolio
  • 6.5.3 Vaccines Market Value Analysis
  • 6.5.4 Recent Development
• 6.6 Mitsubishi Tanabe Pharma
  • 6.6.1 Business Overview
  • 6.6.2 Vaccines Portfolio
  • 6.6.3 Vaccines Market Value Analysis
  • 6.6.4 Promising Vaccines in the Clinical Development
  • 6.6.5 Recent Development
• 6.7 Emergent BioSolutions
  • 6.7.1 Business Overview
  • 6.7.2 Vaccines Portfolio
  • 6.7.3 Vaccines Market Value Analysis
  • 6.7.4 Promising Vaccines in the Clinical Development
  • 6.7.5 Recent Development
• 6.8 Astlellas Pharma Inc
  • 6.8.1 Business Overview
  • 6.8.2 Vaccines Portfolio
  • 6.8.3 Vaccines Market Value Analysis
  • 6.8.4 Recent Development
• 6.9 Valneva
  • 6.9.1 Business Overview
  • 6.9.2 Vaccines Portfolio
  • 6.9.3 Vaccines Market Value Analysis
  • 6.9.4 Promising Vaccines in the Clinical Development
  • 6.9.5 Recent Development
• 6.10 Seqirus (CSL Limited)
  • 6.10.1 Business Overview
  • 6.10.2 Vaccines Portfolio
  • 6.10.3 Vaccines Market Value Analysis
  • 6.10.4 Promising Vaccines in the Clinical Development
  • 6.10.5 Recent Development
• 6.11 Bavarian Nordic
  • 6.11.1 Business Overview
  • 6.11.2 Vaccines Portfolio
  • 6.11.3 Vaccines Market Value Analysis
  • 6.11.4 Promising Vaccines in the Clinical Development
  • 6.11.5 Recent Development
• 6.12 Sinovac
  • 6.12.1 Business Overview
  • 6.12.2 Vaccines Portfolio
  • 6.12.3 Vaccines Market Value Analysis
  • 6.12.4 Promising Vaccines in the Clinical Development
  • 6.12.5 Recent Development
• 6.13 Panacea Biotec
  • 6.13.1 Business Overview
  • 6.13.2 Vaccines Portfolio
  • 6.13.3 Vaccines Market Value Analysis
  • 6.13.4 Promising Vaccines in the Clinical Development
  • 6.13.5 Recent Development
• 6.14 Dynavax Technologies Corporation
  • 6.14.1 Business Overview
  • 6.14.2 Vaccines Portfolio
  • 6.14.3 Vaccines Market Value Analysis
  • 6.14.4 Promising Vaccines in the Clinical Development
  • 6.14.5 Recent Development
• 6.15 Bharat Biotech
  • 6.15.1 Business Overview
  • 6.15.2 Vaccines Portfolio
  • 6.15.3 Promising Vaccines in the Clinical Development
  • 6.15.4 Recent Development
• 6.16 Serum Institute of India
  • 6.16.1 Business Overview
  • 6.16.2 Vaccines Portfolio
  • 6.16.3 Promising Vaccines in Clinical Development
  • 6.16.4 Recent Development
• 6.17 Biological E. Limited
  • 6.17.1 Business Overview
  • 6.17.2 Vaccines Portfolio
  • 6.17.3 Promising Vaccines in the Clinical Development
  • 6.17.4 Recent Development
• 6.18 Grifols
  • 6.18.1 Business Overview
  • 6.18.2 Vaccines Portfolio
  • 6.18.3 Recent Development
• 6.19 Hualan Biological Engineering Inc
  • 6.19.1 Business Overview
  • 6.19.2 Influenza Vaccines Portfolio
  • 6.19.3 Recent Development
• 6.20 Gamma Vaccines Pty Ltd
  • 6.20.1 Business Overview
  • 6.20.2 Influenza Vaccines Portfolio